Skip to content

Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain

Role of Wound Installation With Bupivacaine Through Surgical Drains in Postoperative Analgesia in Modified Radical Mastectomy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03799757
Enrollment
168
Registered
2019-01-10
Start date
2016-01-31
Completion date
2018-12-31
Last updated
2019-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Pain, Postoperative

Keywords

bupivacaine, Post-mastectomy acute pain, Wound instillation

Brief summary

in this study we are investigating the role of instillation of Bupivacaine through surgical drains at the end of mastectomy surgeries in controlling post operative pain and decreasing their pain killers requirement in the early postoperative period

Detailed description

patients were enrolled into 2 groups. in one group the wound was installed by 40ml of 0.25% bupivacaine through axillary and chest wall drains (20ml in each drain). Then, the drains were clamped for 20 minutes. in the other group the wound was installed by 40ml of 0.9% normal saline through axillary and chest wall drains (20ml in each drain). Then, the drains were clamped for 20 minutes. (placebo group) patients and health care providers were blinded as regard the study group patients enrolled in. Visual Analog Pain Scale which is a score for detection of how much the patient is annoyed from the pain- was assessed two and four hours post-operative then every four hours thereafter.

Interventions

DRUG40ml of 0.25% bupivacaine
DRUG40ml of 0.9% normal saline

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

female patients with unilateral breast cancer candidates for total mastectomy and axillary dissection

Exclusion criteria

1. Male patients 2. Bilateral breast cancer. 3. Patients with a history of a long duration of NSAID intake or other painkillers, drug abuse 4. Patients with chest wall pain like Tietze syndrome, history of angina pectoris or recent HZV infection. 5. Patients with known psychological or mental problems. 6. Patients who were not exposed to axillary dissection

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue pain scorefirst 24 hoursThe intensity of pain will be assessed by the VAS score
Number of demands for analgesicFirst 24 hoursHow many times the patient will require analgesics
Timing of first demand for analgesicFirst 24 hoursTime lapse between recovery from surgery and first demand for analgesic

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026